TOBA II BTK Trial Enrollment Ahead Of Schedule For The Tack Endovascular System® In Below The Knee Disease

January 25, 2018 – WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the Tack Optimized Balloon Angioplasty II Below the Knee (TOBA II BTK) clinical trial surpassed the 100 patient milestone, advancing enrollment well ahead of schedule. The TOBA II BTK is a prospective, multi-center, single-arm study designed to investigate the safety and efficacy …

TOBA II BTK Trial Enrollment Ahead Of Schedule For The Tack Endovascular System® In Below The Knee Disease Read More »